1-{3-[(2-([1-(triphenylmethyl)-1H-1,2,4-triazol-3-yl]oxy)ethyl)oxy}phenyl]methanamine → 5,6-difluoro-4-oxo-N-({3-[(2-{[1-(triphenylmethyl)-1H-1,2,4-triazol-3-yl]oxy}ethyl)oxy]phenyl}methyl)-3,4-dihydroquinazoline-2-carboxamide

HRID 606403노트

반응식

HRID 606403 반응식
[C:1]1([C:7]([C:31]2[CH:36]=[CH:35][CH:34]=[CH:33][CH:32]=2)([C:25]2[CH:30]=[CH:29][CH:28]=[CH:27][CH:26]=2)[N:8]2[CH:12]=[N:11][C:10]([O:13][CH2:14][CH2:15][O:16][C:17]3[CH:18]=[C:19]([CH2:23][NH2:24])[CH:20]=[CH:21][CH:22]=3)=[N:9]2)[CH:6]=[CH:5][CH:4]=[CH:3][CH:2]=1.[F:37][C:38]1[C:47]([F:48])=[CH:46][CH:45]=[C:44]2[C:39]=1[C:40](=[O:54])[NH:41][C:42]([C:49](OCC)=[O:50])=[N:43]2>C(O)C>[F:37][C:38]1[C:47]([F:48])=[CH:46][CH:45]=[C:44]2[C:39]=1[C:40](=[O:54])[NH:41][C:42]([C:49]([NH:24][CH2:23][C:19]1[CH:20]=[CH:21][CH:22]=[C:17]([O:16][CH2:15][CH2:14][O:13][C:10]3[N:11]=[CH:12][N:8]([C:7]([C:1]4[CH:6]=[CH:5][CH:4]=[CH:3][CH:2]=4)([C:25]4[CH:26]=[CH:27][CH:28]=[CH:29][CH:30]=4)[C:31]4[CH:36]=[CH:35][CH:34]=[CH:33][CH:32]=4)[N:9]=3)[CH:18]=1)=[O:50])=[N:43]2

참가 물질

4

반응물 2

HCID 667690991-{3-[(2-([1-(triphenylmethyl)-1H-1,2,4-triazol-3-yl]oxy)ethyl)oxy}phenyl]methanamineHCID 136029322Ethyl 5,6-difluoro-4-oxo-3,4-dihydroquinazoline-2-carboxylate

생성물 1

HCID 1363809705,6-difluoro-4-oxo-N-({3-[(2-{[1-(triphenylmethyl)-1H-1,2,4-triazol-3-yl]oxy}ethyl)oxy]phenyl}methyl)-3,4-dihydroquinazoline-2-carboxamide수율 41%

시약·촉매·용매 1

HCID 702Ethanol용매

반응 조건

온도
80 °C

실험 절차

A suspension of 1-{3-[(2-{[1-(triphenylmethyl)-1H-1,2,4-triazol-3-yl]oxy]ethyl)oxy}phenyl}methanamine obtained in Reference Example 32 (300 mg, 1.18 mmol) and ethyl 5,6-difluoro-4-oxo-3,4-dihydroquinazoline-2-carboxylate obtained in Reference Example 57 (562 mg, 1.18 mmol) in ethanol (10 mL) was stirred at 80° C. for 12 hr. The insoluble material was filtered off hot, and the filtrate was allowed to cool to room temperature. The precipitated solid was collected by filtration using glass filter, and the obtained solid was washed with diethyl ether to give 5,6-difluoro-4-oxo-N-({3-[(2-{[1-(triphenylmethyl)-1H-1,2,4-triazol-3-yl]oxy}ethyl)oxy]phenyl}methyl)-3,4-dihydroquinazoline-2-carboxamide as a pale-yellow powder (330 mg, 41%).

후처리

  1. filtrationThe insoluble material was filtered off hot
  2. temperatureto cool to room temperature
  3. filtrationThe precipitated solid was collected by filtration
  4. filtrationfilter
  5. washthe obtained solid was washed with diethyl ether

출처 및 근거

ORD 기록
ord-6155de3ef4504fd9a218d806ba86b3aa
출처 데이터셋
uspto-grants-2011_03
특허 번호
US07915267B2

반응 노트

불러오는 중…